Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombogenesis in sickle cell disease.

A Tomer1, L A Harker, S Kasey

  • 1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30303, USA.

The Journal of Laboratory and Clinical Medicine
|June 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BRCA carriers after risk-reducing bilateral salpingo-oophorectomy: menopausal hormone therapy knowledge gaps, and the impact of physicians' recommendations.

Climacteric : the journal of the International Menopause Society·2023
Same author

Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.

Transfusion medicine (Oxford, England)·2019
Same author

The Structure of Cognitive Speed Measures in Old and Young Adults.

Multivariate behavioral research·2016
Same author

Clinico-demographical profile of keratomycosis in Delhi, North India.

Indian journal of medical microbiology·2014
Same author

The Mayo Clinic and the Canadians.

Canadian Medical Association journal·2010
Same author

Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool.

British journal of haematology·2007

Sickle cell disease (SCD) patients show increased platelet activation and blood clotting markers, even when pain-free. These thrombogenic activities intensify during pain episodes, predicting future pain frequency and interval.

Area of Science:

  • Hematology
  • Vascular Biology
  • Thrombosis

Background:

  • Sickle cell disease (SCD) is characterized by vaso-occlusion and pain crises.
  • The role of thrombogenic activity in SCD pathophysiology requires further elucidation.

Purpose of the Study:

  • To investigate in vivo thrombogenic activities in SCD patients.
  • To compare these activities between pain episodes and pain-free periods.
  • To assess the relationship between thrombogenic markers and pain frequency.

Main Methods:

  • Flow cytometry was used to assess platelet activation (GPIIb/IIIa, P-selectin) and procoagulant activity (FVa, annexin V binding) on platelets and erythrocytes.
  • Plasma levels of platelet factors (PF4, betaTG), thrombin generation markers (F(1.2), TAT), and fibrinolysis markers (D-dimer, PAP) were measured.

Related Experiment Videos

  • Correlations between pain frequency and thrombogenic markers were analyzed.

    • Main Results:

    • Asymptomatic SCD patients exhibited elevated platelet activation, PF4, betaTG, thrombin generation, and fibrinolysis compared to controls.
    • During pain episodes, platelet activation, erythrocyte procoagulant activity, and platelet microparticles significantly increased.
    • SCD pain episodes were associated with higher levels of thrombin generation and fibrinolysis markers.
    • Pain frequency correlated with enhanced platelet procoagulant activity and fibrinolysis during pain-free periods.

    Conclusions:

    • SCD patients exhibit persistent thrombogenic activity, including platelet activation, thrombin generation, and fibrinolysis.
    • These activities escalate during pain episodes, suggesting a role in SCD pathophysiology.
    • Thrombogenic markers may predict pain frequency and recurrence in SCD.